Unicentric Castleman Disease: Updates and Novel Insights Into Spindle Cell Proliferations and Aggressive Forms of a Localized Disease FNU Alnoor, Alexandra Rangel, Matthew Luo, Oscar Silva, Karen M. Chisholm, Dennis O'Malley, Roger Warnke, Jyoti Kumar, Robert S. Ohgami International Journal of Laboratory Hematology.2025; 47(1): 26. CrossRef
Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report Wen Han, Bei Wang, Xiang Yong, Yi Zhang, Mingyu Shao, Chun Wang Pathology and Oncology Research.2023;[Epub] CrossRef
Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma—presentation in novel settings and comprehensive review of literature Alireza Ghezavati, Christine A. Liang, Daniel Mais, Alia Nazarullah Journal of Hematopathology.2023; 16(3): 167. CrossRef
Indolent T-lymphoblastic proliferation: a report of three cases Zheng Yuanyuan, Xie Jianlan, Zhang Yanlin, Zhou Xiaoge Virchows Archiv.2022; 480(5): 1121. CrossRef
Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease Nabin Raj Karki, Ahmed Samire Arfa, Natasha Savage, Abdullah Kutlar Acta Haematologica.2022; 145(2): 214. CrossRef
Indolent T‐lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases Arzu Saglam, Kunwar Singh, Sumanth Gollapudi, Jyoti Kumar, Nivaz Brar, Alexandra Butzmann, Roger Warnke, Robert S. Ohgami International Journal of Laboratory Hematology.2022; 44(4): 700. CrossRef
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici, Amy Chadburn, John K. C. Chan, Wah Cheuk, Wee-Joo Chng, Leukemia.2022; 36(7): 1720. CrossRef
T-lymphoblastic leukemia/lymphoma with interfollicular growth pattern and Castleman-like morphologic features Weijie Li, Alexander Kats, Linda D. Cooley, Midhat S. Farooqi, Keith August Journal of Hematopathology.2021; 14(2): 163. CrossRef
Maladie de Castleman localisée avec prolifération lymphoblastique T indolente Bertrand Chauveau, François Le Loarer, Julia Bacci, François Baylac, Pierre Dubus, Catherine Ling, Marie Parrens Annales de Pathologie.2019; 39(1): 29. CrossRef
Sirolimus for the Treatment of Airway Obstruction due to Indolent T-Lymphoblastic Proliferation Eric Moughames, Ana P. Kiess, Lee M. Akst, Antoine Azar Case Reports in Immunology.2019; 2019: 1. CrossRef
Indolent T‐lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T‐lymphoblastic lymphoma: case report and literature review Hajime Yasuda, Miyuki Tsutsui, Yasunori Ota, Masaru Tanaka, Norio Komatsu Histopathology.2018; 72(5): 862. CrossRef
Indolent T-lymphoblastic proliferation: a name with specific meaning—reply Bharat N. Nathwani, Rina Kansal, Xanthi Yiakoumis, Gerassimos A. Pangalis Human Pathology.2015; 46(11): 1786. CrossRef
Clinical imaging creates visual representations of the body interior for disease assessment. The role of clinical imaging significantly overlaps with that of pathology, and diagnostic workflows largely depend on both fields. The field of clinical imaging is presently undergoing a radical change through the emergence of a new field called molecular imaging. This new technology, which lies at the intersection between imaging and molecular biology, enables noninvasive visualization of biochemical processes at the molecular level within living bodies. Molecular imaging differs from traditional anatomical imaging in that biomarkers known as imaging probes are used to visualize target molecules-of-interest. This ability opens up exciting new possibilities for applications in oncologic, neurological and cardiovascular diseases. Molecular imaging is expected to make major contributions to personalized medicine by allowing earlier diagnosis and predicting treatment response. The technique is also making a huge impact on pharmaceutical development by optimizing preclinical and clinical tests for new drug candidates. This review will describe the basic principles of molecular imaging and will briefly touch on three examples (from an immense list of new techniques) that may contribute to personalized medicine: receptor imaging, angiogenesis imaging, and apoptosis imaging.
Citations
Citations to this article as recorded by
Supramolecular fluorescence biosensing based on macrocycles Jia-Hong Tian, Haiqi Xu, Xin-Yue Hu, Dong-Sheng Guo Supramolecular Materials.2024; 3: 100063. CrossRef
A non-invasive osteopontin-targeted phase changeable fluorescent nanoprobe for molecular imaging of myocardial fibrosis Xueli Zhao, Yuze Qin, Bo Wang, Jiao Liu, Yueyue Wang, Kun Chen, Jia Zhao, Lanlan Zhang, Yuanming Wu, Liwen Liu Nanoscale Advances.2024; 6(14): 3590. CrossRef
The Role of Molecular Imaging in Personalized Medicine Suliman Salih, Aisyah Elliyanti, Ajnas Alkatheeri, Fatima AlYafei, Bashayer Almarri, Hasina Khan Journal of Personalized Medicine.2023; 13(2): 369. CrossRef
Development of a multifunctional platform for near-infrared imaging and targeted radionuclide therapy for tumors Huihui He, Ke Li, Hang Li, Shiliang Zhu, Shuai Qin, Yong Mao, Jianguo Lin, Ling Qiu, Chunjing Yu European Journal of Pharmaceutics and Biopharmaceutics.2023; 185: 107. CrossRef
Quantum Biotechnology Nicolas P. Mauranyapin, Alex Terrasson, Warwick P. Bowen Advanced Quantum Technologies.2022;[Epub] CrossRef
Preparation Fe3O4@chitosan-graphene quantum dots nanocomposites for fluorescence and magnetic resonance imaging Kai Wang, Xiaoguang Xu, Yan Li, Mayifei Rong, Lifeng Wang, Liying Lu, Jian Wang, Fengwen Zhao, Bowen Sun, Yong Jiang Chemical Physics Letters.2021; 783: 139060. CrossRef
Network Medicine: A Clinical Approach for Precision Medicine and Personalized Therapy in Coronary Heart Disease Teresa Infante, Luca Del Viscovo, Maria Luisa De Rimini, Sergio Padula, Pio Caso, Claudio Napoli Journal of Atherosclerosis and Thrombosis.2020; 27(4): 279. CrossRef
Nanodrug Delivery Systems for the Treatment of Ovarian Cancer Jonathan M. Pantshwa, Pierre P. D. Kondiah, Yahya E. Choonara, Thashree Marimuthu, Viness Pillay Cancers.2020; 12(1): 213. CrossRef
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer V. M. Baart, R. D. Houvast, L. F. de Geus-Oei, P. H. A. Quax, P. J. K. Kuppen, A. L. Vahrmeijer, C. F. M. Sier EJNMMI Research.2020;[Epub] CrossRef
In vivo SPECT imaging of an 131I-labeled PM 2.5 mimic substitute Dong-Hui Pan, Jie Sheng, Xin-Yu Wang, Qian-Huan Huang, Jun-Jie Yan, Li-Zhen Wang, Run-Ling Yang, Dong-Jian Shi, Yu-Ping Xu, Ming-Qing Chen Nuclear Science and Techniques.2020;[Epub] CrossRef
Optofluidics in bio-imaging applications Sihui Chen, Rui Hao, Yi Zhang, Hui Yang Photonics Research.2019; 7(5): 532. CrossRef
Nitrogen-vacancy centers in diamond for nanoscale magnetic resonance imaging applications Alberto Boretti, Lorenzo Rosa, Jonathan Blackledge, Stefania Castelletto Beilstein Journal of Nanotechnology.2019; 10: 2128. CrossRef
Online molecular image repository and analysis system: A multicenter collaborative open-source infrastructure for molecular imaging research and application Mahabubur Rahman, Hiroshi Watabe Computers in Biology and Medicine.2018; 96: 233. CrossRef
Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure–Activity Relationships, and Pharmacokinetic Profiling Robert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, Elisabeth Jäckel, David Bauer, Martin Lohse, Alan Wong, Johanna Pufe, Friedrich-Alexander Ludwig, Steffen Fischer, Sandra Hauser, Dieter Greif, M. Teresa Pisabarro, Jens Pietzsch, Markus Pietsch, Reik Lö Journal of Medicinal Chemistry.2018; 61(10): 4528. CrossRef
Genomic Interventions in Medicine Oluwadurotimi S Aworunse, Oluwatomiwa Adeniji, Olusola L Oyesola, Itunuoluwa Isewon, Jelili Oyelade, Olawole O Obembe Bioinformatics and Biology Insights.2018;[Epub] CrossRef
Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI Ryan L. Brunsing, Natalie M. Schenker-Ahmed, Nathan S. White, J. Kellogg Parsons, Christopher Kane, Joshua Kuperman, Hauke Bartsch, Andrew Karim Kader, Rebecca Rakow-Penner, Tyler M. Seibert, Daniel Margolis, Steven S. Raman, Carrie R. McDonald, Nikdokht Journal of Magnetic Resonance Imaging.2017; 45(2): 323. CrossRef
Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium Orazio Schillaci, Nicoletta Urbano European Journal of Nuclear Medicine and Molecular Imaging.2017; 44(4): 563. CrossRef
Nano-Magnetic Resonance Imaging (Nano-MRI) Gives Personalized Medicine a New Perspective Lorenzo Rosa, Jonathan Blackledge, Albert Boretti Biomedicines.2017; 5(1): 7. CrossRef
Optical nanoprobes for biomedical applications: shining a light on upconverting and near-infrared emitting nanoparticles for imaging, thermal sensing, and photodynamic therapy E. Hemmer, P. Acosta-Mora, J. Méndez-Ramos, S. Fischer Journal of Materials Chemistry B.2017; 5(23): 4365. CrossRef
Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma Senthilkumar Kalimuthu, Ju Hye Jeong, Ji Min Oh, Byeong-Cheol Ahn International Journal of Molecular Sciences.2017; 18(8): 1639. CrossRef
Chemistry and engineering of cyclodextrins for molecular imaging Wing-Fu Lai, Andrey L. Rogach, Wing-Tak Wong Chemical Society Reviews.2017; 46(20): 6379. CrossRef
Prototypes of Lanthanide(III) Agents Responsive to Enzymatic Activities in Three Complementary Imaging Modalities: Visible/Near-Infrared Luminescence, PARACEST-, and T1-MRI Jiefang He, Célia S. Bonnet, Svetlana V. Eliseeva, Sara Lacerda, Thomas Chauvin, Pascal Retailleau, Frederic Szeremeta, Bernard Badet, Stéphane Petoud, Éva Tóth, Philippe Durand Journal of the American Chemical Society.2016; 138(9): 2913. CrossRef
Nanoparticles in practice for molecular-imaging applications: An overview Parasuraman Padmanabhan, Ajay Kumar, Sundramurthy Kumar, Ravi Kumar Chaudhary, Balázs Gulyás Acta Biomaterialia.2016; 41: 1. CrossRef
A new neuroinformatics approach to personalized medicine in neurology: The Virtual Brain Maria I. Falcon, Viktor Jirsa, Ana Solodkin Current Opinion in Neurology.2016; 29(4): 429. CrossRef
Targeted multimodal nano-reporters for pre-procedural MRI and intra-operative image-guidance Joonseok Lee, Andrew C. Gordon, Hacksung Kim, Wooram Park, Soojeong Cho, Byeongdu Lee, Andrew C. Larson, Elena A. Rozhkova, Dong-Hyun Kim Biomaterials.2016; 109: 69. CrossRef
Pancreatic cancer is a deadly disease with a dismal prognosis. However, recent advances in sequencing and bioinformatic technology have led to the systematic characterization of the genomes of all major tumor types in the pancreas. This characterization has revealed the unique genomic landscape of each tumor type. This knowledge will pave the way for improved diagnostic and therapeutic approaches to pancreatic tumors that take advantage of the genetic alterations in these neoplasms.
Citations
Citations to this article as recorded by
c-Myc inhibition and p21 modulation contribute to unsymmetrical bisacridines-induced apoptosis and senescence in pancreatic cancer cells Agnieszka Kurdyn, Monika Pawłowska, Ewa Paluszkiewicz, Mirosława Cichorek, Ewa Augustin Pharmacological Reports.2025; 77(1): 182. CrossRef
Evaluation of the Value of Fine Needle Aspiration Cytology and Cell Morphology in Determining the Histogenesis of Pancreatic Lesions With Review of Literature, Overview and Cytological Experience of 25 Years: Original Research Soudah Bisharah, Abbas Mahmoud Health Science Reports.2025;[Epub] CrossRef
Research of immunotherapy in pancreatic cancer Zetian Li, Y.-T. Yu, P.P. Piccaluga, S. Xie BIO Web of Conferences.2024; 111: 02026. CrossRef
Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography–based radiomics and genetic alterations of pancreatic ductal adenocarcinoma Chae Hong Lim, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Jong Kyun Lee, Ji Hye Min, Seung Hyup Hyun European Journal of Nuclear Medicine and Molecular Imaging.2020; 47(9): 2113. CrossRef
NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS Mitali Chattopadhyay, Ravinder Kodela, Gabriela Santiago, Thuy Tien C. Le, Niharika Nath, Khosrow Kashfi Biochemical Pharmacology.2020; 176: 113857. CrossRef
Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising? Friederike Inga Nollmann, Dietrich Alexander Ruess Biomedicines.2020; 8(8): 281. CrossRef
Ancillary Techniques in Cytologic Specimens Obtained from Solid Lesions of the Pancreas: A Review Jonas J. Heymann, Momin T. Siddiqui Acta Cytologica.2020; 64(1-2): 103. CrossRef
DNA polymerase η mutational signatures are found in a variety of different types of cancer Igor B. Rogozin, Alexander Goncearenco, Artem G. Lada, Subhajyoti De, Vyacheslav Yurchenko, German Nudelman, Anna R. Panchenko, David N. Cooper, Youri I. Pavlov Cell Cycle.2018; 17(3): 348. CrossRef
Genetics of Pancreatic Neoplasms and Role of Screening Venkata S. Katabathina, Omid Y. Rikhtehgar, Anil K. Dasyam, Rohan Manickam, Srinivasa R. Prasad Magnetic Resonance Imaging Clinics of North America.2018; 26(3): 375. CrossRef
Team work and cytopathology molecular diagnosis of solid pancreatic lesions Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli, Marco Bassi, Stefania Ghersi, Giovanni Tallini, Elio Jovine, Antonio Gasbarrini, Dario de Digestive Endoscopy.2017; 29(6): 657. CrossRef
Mutational signatures and mutable motifs in cancer genomes Igor B. Rogozin, Youri I. Pavlov, Alexander Goncearenco, Subhajyoti De, Artem G. Lada, Eugenia Poliakov, Anna R. Panchenko, David N. Cooper Briefings in Bioinformatics.2017;[Epub] CrossRef
The evolving field of genomic biomarkers to characterize pancreatic cystic neoplasia by EUS-guided FNA Ferga C. Gleeson, Michael J. Levy Gastrointestinal Endoscopy.2016; 83(1): 149. CrossRef
MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors Rui Gradiz, Henriqueta C. Silva, Lina Carvalho, Maria Filomena Botelho, Anabela Mota-Pinto Scientific Reports.2016;[Epub] CrossRef
p53 and p16/p19 Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells Stephanie Azzopardi, Sharon Pang, David S. Klimstra, Yi-Chieh Nancy Du Neoplasia.2016; 18(10): 610. CrossRef
MicroRNA-506 participates in pancreatic cancer pathogenesis by targeting PIM3 JUNDONG DU, XI ZHENG, SHOUWANG CAI, ZIMAN ZHU, JINGWANG TAN, BIN HU, ZHIQIANG HUANG, HUABO JIAO Molecular Medicine Reports.2015; 12(4): 5121. CrossRef
Background Counting mitoses is subjective and time-consuming. The adjunctive diagnostic utility of a recently reported mitotic marker, phosphohistone H3 (PHH3), was investigated in gastrointestinal stromal tumors (GISTs). Methods: We reviewed 77 GISTs for several proliferative indices. These included the mitotic count per 50 high power fields (HPFs), the immunohistochemical Ki- 67 labeling index and the immunohistochemical PHH3 mitotic index (MI). For comparison, Spearman’s rank correlation and interclass correlation coefficient were used. Results: Mitotic counts ranged from 0–138 (mean, 7.57±2.34) and the PHH3 MI ranged from 0–126 per 50 HPFs (mean, 9.61±2.27). We found a positive correlation between mitotic counts and PHH3 MI (r=0.810, p<.001). The inter-observer correlation coefficient for three participants was 0.975 for mitotic counts and 0.940 for the PHH3 MI. When using the PHH3 MI instead of mitotic counts in the Armed Forces Institute of Pathology (AFIP) stratification criteria, 10 cases were reclassified. In one patient with a mitotic count of 2 and a PHH3 MI of 6 per 50 HPFs, distant metastasis occurred. Conclusions: In GISTs, the PHH3 MI correlated adequately with mitotic counts and can be used as a useful adjunctive to count mitotic figures efficiently.
Citations
Citations to this article as recorded by
Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review Aryan Salahi‐Niri, Paniz Zarand, Negar Mansouri, Parvaneh Rastgou, Omid Yazdani, Romina Esbati, Fatemeh Shojaeian, Behnaz Jahanbin, Zhaleh Mohsenifar, Hamid Asadzadeh Aghdaei, Farid Azmoudeh Ardalan, Seyed Amir Ahmad Safavi‐Naini Health Science Reports.2025;[Epub] CrossRef
A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms Gaoxiu Qi, Jinmeng Liu, Shuqi Tao, Wenyuan Fan, Haoning Zheng, Meihong Wang, Hanchao Yang, Yongting Liu, Huancai Liu, Fenghua Zhou PeerJ.2023; 11: e15675. CrossRef
Loss of Slfn3 induces a sex-dependent repair vulnerability after 50% bowel resection Emilie E. Vomhof-DeKrey, Jack T. Lansing, Diane C. Darland, Josey Umthun, Allie D. Stover, Christopher Brown, Marc D. Basson American Journal of Physiology-Gastrointestinal and Liver Physiology.2021; 320(2): G136. CrossRef
Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies Napaporn Puripat, Kongsak Loharamtaweethong Virchows Archiv.2019; 474(1): 87. CrossRef
Gastrointestinal Stromal Tumors Risk Stratification Utilizing Phospho-Histone H3 Evaluated by Manual Counting and Computer-Assisted Image Analysis Cao Jin, Yan Huang, Mansoor Nasim, Yihe Yang, Lili Lee International Journal of Surgical Pathology.2019; 27(7): 706. CrossRef
The utility of phosphohistone H3 in early prediction of benign and borderline phyllodes tumor recurrence AymenM El-Saka, MohamedA Mlees, YomnaA Zamzam Egyptian Journal of Pathology.2019; 39(2): 402. CrossRef
Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors Min Jeong Kim, Mi Jung Kwon, Ho Suk Kang, Kyung Chan Choi, Eun Sook Nam, Seong Jin Cho, Hye-Rim Park, Soo Kee Min, Jinwon Seo, Ji-Young Choe, Hyoung-Chul Park BioMed Research International.2018; 2018: 1. CrossRef
Tumor Digital Masking Allows Precise Patient Triaging: A Study Based on Ki-67 Scoring in Gastrointestinal Stromal Tumors Piotr Lewitowicz, Jaroslaw Matykiewicz, Magdalena Chrapek, Dorota Koziel, Agata Horecka-Lewitowicz, Martyna Gluszek-Osuch, Iwona Wawrzycka, Stanisław Gluszek Scanning.2018; 2018: 1. CrossRef
The mitosis‐specific marker phosphohistone‐H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome‐based study Kin‐Long Chow, Ka‐Yu Tse, Ching‐Lung Cheung, Ka‐Wing Wong, Annie N Y Cheung, Richard W C Wong, Alice N H Chan, Nancy W F Yuen, Hextan Y S Ngan, Philip P C Ip Histopathology.2017; 70(5): 746. CrossRef
Background Pancreatic neuroendocrine tumors (PanNETs) are malignant endocrine neoplasms that present diverse clinical behaviors. Therefore, identification of biomarkers of PanNETs is important for stratification of the prognosis of PanNET patients. Recently, cytokeratin 19 (CK19) and KIT expression were reported to have prognostic significance in PanNET patients. Methods: To identify their prognostic significance, CK19 and KIT protein expression were assessed in 182 surgically resected PanNETs and compared with clinicopathologic factors. Results: Of 182 PanNETs cases, CK19 and KIT expression was noted in 97 (53.3%) and 16 (8.8%) cases, respectively. PanNET patients with CK19 expression had larger tumors (p=.006), higher World Health Organization (WHO) grade (p=.002) and pT classification (p<.001), increased distant metastasis (p=.004), and lymphovascular (p=.012) and perineural (p=.019) invasion. Similarly, those with KIT expression had larger tumors (p=.030), higher WHO grade (p=.001), advanced pT classification (p<.001), distant metastasis (p=.001), and lymphovascular invasion (p=.014). The 5-year survival rate for PanNET patients with KIT expression was significantly lower (62%) than that of patients without KIT expression (77%, p=.011), as determined by univariate but not by multivariate analyses. Conclusions: CK19 and KIT expression correlate with higher metastatic potential and advanced disease stage, and KIT expression is associated with worse survival in PanNET patients.
Citations
Citations to this article as recorded by
Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy Kahoko Maeda, Takeshi Uehara, Waki Hosoda, Yasuhiro Kuraishi, Hiroyoshi Ota Pathology - Research and Practice.2024; 262: 155537. CrossRef
Glypican-3 and Cytokeratin-19 Expression in Pancreatic Cancer in a Canadian Population Carley Bekkers, Ravi Ramjeesingh, Thomas Arnason Journal of Clinical Medicine.2024; 13(22): 6893. CrossRef
Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor Bokyung Ahn, Joo Young Kim, Seung-Mo Hong Archives of Pathology & Laboratory Medicine.2023; 147(1): 100. CrossRef
Tumor-associated nonmyelinating Schwann cell–expressed
PVT1
promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
Chengcao Sun, Youqiong Ye, Zhi Tan, Yuan Liu, Yajuan Li, Wei Hu, Ke Liang, Sergey D. Egranov, Lisa Angela Huang, Zhao Zhang, Yaohua Zhang, Jun Yao, Tina K. Nguyen, Zilong Zhao, Andrew Wu, Jeffrey R. Marks, Abigail S. Caudle, Aysegul A. Sahin, Jianjun Gao, Science Advances.2023;[Epub] CrossRef
Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors Anne Menz, Rifka Bauer, Martina Kluth, Clara Marie von Bargen, Natalia Gorbokon, Florian Viehweger, Maximilian Lennartz, Cosima Völkl, Christoph Fraune, Ria Uhlig, Claudia Hube-Magg, Noémi De Wispelaere, Sarah Minner, Guido Sauter, Simon Kind, Ronald Simo Human Pathology.2021; 115: 19. CrossRef
The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities Kate Young, Naureen Starling, Anguraj Sadanandam Seminars in Cancer Biology.2020; 61: 132. CrossRef
Pancreatic acinar cell carcinomas and mixed acinar-neuroendocrine carcinomas are more clinically aggressive than grade 1 pancreatic neuroendocrine tumours Joo Young Kim, Jacqueline A. Brosnan-Cashman, Jiyoon Kim, Soyeon An, Kyoung-Bun Lee, Haeryoung Kim, Do Youn Park, Kee-Taek Jang, Young-Ha Oh, Ralph H. Hruban, Christopher M. Heaphy, Seung-Mo Hong Pathology.2020; 52(3): 336. CrossRef
Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification Yue Xue, Michelle D. Reid, Burcin Pehlivanoglu, Rebecca C. Obeng, Hongmei Jiang, Bahar Memis, Shu K. Lui, Juan Sarmiento, David Kooby, Shishir K. Maithel, Bassel El-Rayes, Olca Basturk, Volkan Adsay Endocrine Pathology.2020; 31(3): 239. CrossRef
Histological grades and prognostic markers of well-differentiated pancreatic neuroendocrine tumor (WDPNET) Yongchao Li, Daniel Rowan, Claire P. Williamson, Meiyun Fan, Ali G. Saad, Lizhi Zhang Journal of Pancreatology.2020; 3(4): 188. CrossRef
Clinical and histopathologic prognostic implications of the expression of cytokeratins 8, 10, 13, 14, 16, 18 and 19 in oral and oropharyngeal squamous cell carcinoma Rima A. Safadi, Niveen I. Abdullah, Rolla F. Alaaraj, Dima H. Bader, Darshan D. Divakar, Abed A. Hamasha, Maher A. Sughayer Archives of Oral Biology.2019; 99: 1. CrossRef
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies Lingaku Lee, Tetsuhide Ito, Robert T Jensen Expert Review of Anticancer Therapy.2019; 19(12): 1029. CrossRef
Carbonic anhydrase 9 expression in well-differentiated pancreatic neuroendocrine neoplasms might be associated with aggressive behavior and poor survival Joo Young Kim, Sang Hwa Lee, Soyeon An, Sung Joo Kim, You-Na Sung, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Seung-Mo Hong Virchows Archiv.2018; 472(5): 739. CrossRef
CD133 expression in well-differentiated pancreatic neuroendocrine tumors: a potential predictor of progressive clinical courses Yasuhiro Sakai, Seung-Mo Hong, Soyeon An, Joo Young Kim, Denis Corbeil, Jana Karbanová, Kyoko Otani, Kohei Fujikura, Ki-Byung Song, Song Cheol Kim, Masayuki Akita, Yoshihide Nanno, Hirochika Toyama, Takumi Fukumoto, Yonson Ku, Takanori Hirose, Tomoo Itoh, Human Pathology.2017; 61: 148. CrossRef
Prognostic and predictive biomarkers in neuroendocrine tumours David L. Chan, Stephen J. Clarke, Connie I. Diakos, Paul J. Roach, Dale L. Bailey, Simron Singh, Nick Pavlakis Critical Reviews in Oncology/Hematology.2017; 113: 268. CrossRef
Loss of Progesterone Receptor Expression Is an Early Tumorigenesis Event Associated with Tumor Progression and Shorter Survival in Pancreatic Neuroendocrine Tumor Patients Sung Joo Kim, Soyeon An, Jae Hoon Lee, Joo Young Kim, Ki-Byung Song, Dae Wook Hwang, Song Cheol Kim, Eunsil Yu, Seung-Mo Hong Journal of Pathology and Translational Medicine.2017; 51(4): 388. CrossRef
Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis Dong Cen, Jiang Chen, Zheyong Li, Jie Zhao, Xiujun Cai, Aamir Ahmad PLOS ONE.2017; 12(11): e0187588. CrossRef
A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases Liangtao Ye, Huilin Ye, Quanbo Zhou, Zhihua Li, Qing Lin, Langping Tan, Wenchao Gao, Zhiqiang Fu, Shangyou Zheng, Rufu Chen International Journal of Surgery.2016; 29: 108. CrossRef
Correlating and Combining Genomic and Proteomic Assessment withIn VivoMolecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management? Bhakti Basu, Sandip Basu Cancer Biotherapy and Radiopharmaceuticals.2016; 31(3): 75. CrossRef
Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts Joo Young Kim, Seung-Mo Hong Archives of Pathology & Laboratory Medicine.2016; 140(5): 437. CrossRef
Background A few recent studies have demonstrated a possible role of transglutaminase 2 (TG2) in tumorigenesis or progression of renal cell carcinoma (RCC). The aim of this study was to examine TG2 expression and its clinicopathologic significance in a large number of human clear cell RCCs (CCRCCs). Methods: We analyzed 638 CCRCC patients who underwent partial or radical nephrectomy between 1995 and 2005. The expression of TG2 was determined by immunohistochemistry and categorized into four groups, according to staining intensity: negative (0), mild (1+), moderate (2+), and strong (3+). Results: TG2 staining intensity was negative in 8.5% of CCRCC (n=54), 1+ in 32.6% (n=208), 2+ in 50.5% (n=322), and 3+ in 8.5% (n=54). Strong TG2 expression was correlated with high Fuhrman nuclear grade (p=.011), high T category (p=.049), metastasis (p=.043) and male sex (p<.001) but not with N category.The survival analysis showed a significant association between strong TG2 expression and worse overall and cancer-specific survival (p=.027 and p=.010, respectively). On multivariate analysis, strong TG2 expression was a marginally significant prognostic indicator for Fuhrman nuclear grade and TNM staging (p=.054). Conclusions: Our study is the first to demonstrate the clinicopathologic significance of TG2 expression in a large number of human CCRCC samples. Strong TG2 expression was associated with high nuclear grade and poor prognosis.
Citations
Citations to this article as recorded by
Sex-mediated effects of transglutaminase 2 inhibition on endothelial function in human resistance arteries from diabetic and non-diabetic patients Khatera Saii, Judit Prat-Duran, Ulf Simonsen, Anders Riegels Knudsen, Jonas Amstrup Funder, Niels Henrik Buus, Estéfano Pinilla Clinical Science.2025; 139(1): 1. CrossRef
Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma Ga-Ram Kim, Joon Hee Kang, Hyeon Joo Kim, Eunji Im, Jinsu Bae, Woo Sun Kwon, Sun Young Rha, Hyun Cheol Chung, Eun Yi Cho, Soo-Youl Kim, Yong-Chul Kim Bioorganic Chemistry.2024; 143: 107061. CrossRef
Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target Patrizia Malkomes, Ilaria Lunger, Elsie Oppermann, Johannes Lorenz, Sara Fatima Faqar-Uz-Zaman, Jiaoyan Han, Sabrina Bothur, Paul Ziegler, Katrin Bankov, Peter Wild, Wolf Otto Bechstein, Michael A. Rieger Cancer Gene Therapy.2023; 30(10): 1346. CrossRef
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma Silvia Muccioli, Valentina Brillo, Tatiana Varanita, Federica Rossin, Elisabetta Zaltron, Angelo Velle, Giorgia Alessio, Beatrice Angi, Filippo Severin, Anna Tosi, Manuela D’Eletto, Luca Occhigrossi, Laura Falasca, Vanessa Checchetto, Roberto Ciaccio, Ame Cell Death & Disease.2023;[Epub] CrossRef
The role of transglutaminase 2 in regulation of the balance between autophagy and apoptosis in tumor cells Yu. A. Gnennaya, O. M. Semenov, N. A. Barlev Advances in Molecular Oncology.2023; 10(4): 31. CrossRef
Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates Sandra Hauser, Paul Sommerfeld, Johanna Wodtke, Christoph Hauser, Paul Schlitterlau, Jens Pietzsch, Reik Löser, Markus Pietsch, Robert Wodtke International Journal of Molecular Sciences.2022; 23(9): 4475. CrossRef
The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment Robert Tempest, Sonia Guarnerio, Rawan Maani, Jamie Cooper, Nicholas Peake Cancers.2021; 13(11): 2788. CrossRef
A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2 Soo-Youl Kim, Jeffrey W. Keillor International Journal of Molecular Sciences.2020; 21(7): 2493. CrossRef
Evaluation of nuclear NF-κB, transglutaminase2, and ERCC1 as predictors of platinum resistance in testicular tumors Alan A. Azambuja, Paula Engroff, Bruna T. Silva, Roberta C. S. Zorzetti, Fernanda B. Morrone International braz j urol.2020; 46(3): 353. CrossRef
Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma Seon-Hyeong Lee, Joon Hee Kang, Ji Sun Ha, Jae-Seon Lee, Su-Jin Oh, Hyun-Jung Choi, Jaewhan Song, Soo-Youl Kim International Journal of Molecular Sciences.2020; 21(14): 5042. CrossRef
Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression Burge Ulukan, Ajna Bihorac, Tarik Sipahioglu, Robert Kiraly, Laszlo Fesus, Dilek Telci ACS Omega.2020; 5(43): 28273. CrossRef
Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma Ayca Ece Nezir, Burge Ulukan, Dilek Telci Medical Sciences.2019; 7(2): 24. CrossRef
Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target Richard L. Eckert Molecular Carcinogenesis.2019; 58(6): 837. CrossRef
Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus Nayeon Kim, Joon Hee Kang, Won-Kyu Lee, Seul-Gi Kim, Jae-Seon Lee, Seon-Hyeong Lee, Jong Bae Park, Kyung-Hee Kim, Young-Dae Gong, Kwang Yeon Hwang, Soo-Youl Kim Amino Acids.2018; 50(11): 1583. CrossRef
Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition Seon-Hyeong Lee, Won-Kyu Lee, Nayeon Kim, Joon Hee Kang, Kyung-Hee Kim, Seul-Gi Kim, Jae-Seon Lee, Soohyun Lee, Jongkook Lee, Jungnam Joo, Woo Sun Kwon, Sun Young Rha, Soo-Youl Kim Cancers.2018; 10(11): 455. CrossRef
Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma Yesim Bagatur, Ayca Zeynep Ilter Akulke, Ajna Bihorac, Merve Erdem, Dilek Telci Cell Adhesion & Migration.2017; : 1. CrossRef
Characterization of clear cell renal cell carcinoma by gene expression profiling Bryan J. Thibodeau, Matthew Fulton, Laura E. Fortier, Timothy J. Geddes, Barbara L. Pruetz, Samreen Ahmed, Amy Banes-Berceli, Ping L. Zhang, George D. Wilson, Jason Hafron Urologic Oncology: Seminars and Original Investigations.2016; 34(4): 168.e1. CrossRef
Prognostic role of tissue transglutaminase 2 in colon carcinoma María Jesús Fernández-Aceñero, Sofía Torres, Irene Garcia-Palmero, Cristina Díaz del Arco, J. Ignacio Casal Virchows Archiv.2016; 469(6): 611. CrossRef
Background Meningiomas show high recurrence rates even after curative tumor removal. The invasiveness of meningiomas may contribute to their high recurrence rates. Recently, c-MET and hepatocyte growth factor (HGF) have been reported to be involved in cancer invasion. Methods: We examined the immunohistochemical expression of c-MET and HGF in 100 cases of patients with meningiomas who have undergone complete tumor removal. Results: c-MET-High and HGFHigh were found in 17% and 13% of meningiomas, respectively. Brain invasion was observed in 17.6% of c-MET-High meningiomas, but in only 2.4% of c-MET-Low meningiomas (p=.033). Bone/ soft tissue invasion was observed in 23.5% of c-MET-High meningiomas and in 9.6% of c-MET-Low meningiomas (p=.119). HGF-High did not show statistical association with brain invasion or bone/ soft tissue invasion. c-MET-High demonstrated shorter recurrence-free survival (RFS, 93.5±8.2 months vs 96.1±1.9 months); however, this difference was not statistically significant (p=.139). There was no association of HGF-High with RFS. Conclusions: This study demonstrates that c- MET-High is associated with brain invasion of meningiomas, and that c-MET expression may be a useful predictive marker for meningioma recurrence. Patients with invasive meningiomas with high expressions of c-MET may be good candidates for targeted therapy using c-MET inhibitors.
Citations
Citations to this article as recorded by
MRI morphological features combined with apparent diffusion coefficient can predict brain invasion in meningioma Xiaoyu Huang, Yuntai Cao, Guojin Zhang, FuQiang Tang, Dandan Sun, Jialiang Ren, Wenyi Li, Junlin Zhou, Jing Zhang Computers in Biology and Medicine.2025; 187: 109763. CrossRef
Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors Swati Sharma, Rashmi Rana, Prem Prakash, Nirmal Kumar Ganguly Molecular and Cellular Biochemistry.2024; 479(1): 127. CrossRef
The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion Jun Jiang, Juan Yu, Xiajing Liu, Kan Deng, Kaichao Zhuang, Fan Lin, Liangping Luo Frontiers in Oncology.2023;[Epub] CrossRef
The Role of Pharmacotherapy in Treatment of Meningioma: A Systematic Review Ataollah Shahbandi, Darsh S. Shah, Caroline C. Hadley, Akash J. Patel Cancers.2023; 15(2): 483. CrossRef
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead Yi Li, Jan Drappatz Expert Review of Neurotherapeutics.2023; 23(11): 995. CrossRef
Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases Thiébaud Picart, Chloé Dumot, Jacques Guyotat, Vladislav Pavlov, Nathalie Streichenberger, Alexandre Vasiljevic, Tanguy Fenouil, Anne Durand, Emmanuel Jouanneau, François Ducray, Timothée Jacquesson, Moncef Berhouma, David Meyronet Neurosurgical Review.2022; 45(4): 2797. CrossRef
Nomogram based on MRI can preoperatively predict brain invasion in meningioma Jing Zhang, Yuntai Cao, Guojin Zhang, Zhiyong Zhao, Jianqing Sun, Wenyi Li, Jialiang Ren, Tao Han, Junlin Zhou, Kuntao Chen Neurosurgical Review.2022; 45(6): 3729. CrossRef
Overexpression of Hepatocyte growth factor and its soluble receptor (s-cMet) in the serum of patients with different grades of meningioma Farhad Mashayekhi, Soheila Talesh Sasani, Alia Saberi, Zivar Salehi Journal of Clinical Neuroscience.2021; 93: 1. CrossRef
YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas Kathleen M. Schieffer, Vibhuti Agarwal, Stephanie LaHaye, Katherine E. Miller, Daniel C. Koboldt, Tara Lichtenberg, Kristen Leraas, Patrick Brennan, Benjamin J. Kelly, Erin Crist, Jerome Rusin, Jonathan L. Finlay, Diana S. Osorio, Eric A. Sribnick, Jeffre American Journal of Surgical Pathology.2021; 45(3): 329. CrossRef
Regression of Intracranial Meningiomas Following Treatment with Cabozantinib Rupesh Kotecha, Raees Tonse, Haley Appel, Yazmin Odia, Ritesh R. Kotecha, Guilherme Rabinowits, Minesh P. Mehta Current Oncology.2021; 28(2): 1537. CrossRef
Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis Satoshi Nakasu, Yoko Nakasu Brain Tumor Pathology.2021; 38(2): 81. CrossRef
Curcumin Inhibits HGF-Induced EMT by Regulating c-MET-Dependent PI3K/Akt/mTOR Signaling Pathways in Meningioma Xiaodong Chen, Fen Tian, Peng Lun, Yugong Feng, Ho Lin Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1. CrossRef
Letter to the Editor. Preoperative seizures as predictive sign of brain invasion by meningioma Mikhail F. Chernov Journal of Neurosurgery.2019; 130(3): 1030. CrossRef
Investigating Trk Protein Expression between Oropharyngeal and Non-oropharyngeal Squamous Cell Carcinoma: Clinical Implications and Possible Roles of Human Papillomavirus Infection Yoon Ah Cho, Ji Myung Chung, Hyunmi Ryu, Eun Kyung Kim, Byoung Chul Cho, Sun Och Yoon Cancer Research and Treatment.2019; 51(3): 1052. CrossRef
Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging Alborz Adeli, Katharina Hess, Christian Mawrin, Eileen Maria Susanne Streckert, Walter Stummer, Werner Paulus, André Kemmling, Markus Holling, Walter Heindel, Rene Schmidt, Dorothee Cäcilia Spille, Peter B. Sporns, Benjamin Brokinkel Oncotarget.2018; 9(89): 35974. CrossRef
Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature A. Paix, W. Waissi, D. Antoni, R. Adeduntan, G. Noël Cancer/Radiothérapie.2017; 21(1): 55. CrossRef
Letter: Brain Invasion in Meningiomas—Sex-Associated Differences are not Related to Estrogen- and Progesterone Receptor Expression Katharina Heß, Dorothee Cäcilia Spille, Andrea Wagner, Walter Stummer, Werner Paulus, Benjamin Brokinkel Neurosurgery.2017; 81(2): E25. CrossRef
Brain invasion in meningiomas—clinical considerations and impact of neuropathological evaluation: a systematic review Benjamin Brokinkel, Katharina Hess, Christian Mawrin Neuro-Oncology.2017; 19(10): 1298. CrossRef
Systemic therapy for recurrent meningioma E. Le Rhun, S. Taillibert, M. C. Chamberlain Expert Review of Neurotherapeutics.2016; 16(8): 889. CrossRef
Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis Dorothee Cäcilia Spille, Katharina Heß, Cristina Sauerland, Nader Sanai, Walter Stummer, Werner Paulus, Benjamin Brokinkel World Neurosurgery.2016; 93: 346. CrossRef
Background Endoscopic ultrasound–guided fine needle aspiration cytology (EUS-FNAC) is currently the most commonly used procedure for obtaining cytologic specimens of the pancreas. It is accurate, minimally invasive, safe and cost-effective. However, there is discrepancy between cytological and surgical diagnoses. This study was aimed at evaluating the diagnostic accuracy of EUS-FNAC of the pancreas. Methods: We performed a retrospective review of 191 cases of pancreatic lesions initially diagnosed by EUS-FNAC with subsequent histological diagnosis between 2010 and 2012 in the Department of Pathology, Seoul National University Hospital. Cytologic and surgical diagnoses were categorized into five groups: negative, benign, atypical, malignant, and insufficient for diagnosis. Subsequently, 167 cases with satisfactory yield in both surgical and cytology specimens were statistically analyzed to determine correlations with diagnosis. Results: In comparison to surgical diagnoses, cytologic diagnoses were true-positive in 103 cases (61.7%), true-negative in 28 cases (16.8%), false-positive in 9 cases (5.4%), and false-negative in 27 cases (16.1%). The diagnostic accuracy was 78.4%, sensitivity was 79.2%, and specificity was 75.7%. The positive predictive value was 92.0%, and negative predictive value was 50.9%. Conclusions: EUS-FNAC has high accuracy, sensitivity, specificity and positive predictive value. Overcoming the limitations of EUS-FNAC will make it a useful and reliable diagnostic tool for accurate evaluation of pancreatic lesions.
Citations
Citations to this article as recorded by
miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Hiroki Ueda, Hidenori Takahashi, Shogo Kobayashi, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi Annals of Surgical Oncology.2025; 32(2): 720. CrossRef
Grading pancreatic adenocarcinomas on fine needle aspiration cytology. The outstanding issues Mrinmay Kumar Mallik, Laila Rafiq Qadan, Asit Kumar Mohanty, Ali Alali, Kusum Kapila Cytopathology.2024; 35(2): 256. CrossRef
Reporting Pancreatic FNAC using the Papanicolaou System: Still a Diagnostic Challenge Parul Verma, Saloni Goyal, Ruchita Tyagi, Mehar Ghuman, Ramit Mahajan, Arshneet Kaur Selhi, Harpreet Kaur, Pavneet Kaur Selhi Journal of Cytology.2024; 41(2): 123. CrossRef
Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis Hiroki Ueda, Hidenori Takahashi, Ryoto Sakaniwa, Tetsuhisa Kitamura, Shogo Kobayashi, Yoshito Tomimaru, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi Pancreatology.2024; 24(7): 1097. CrossRef
Comparison of Endoscopic Ultrasound-Guided Fine-Needle Aspiration with Fine-Needle Biopsy for Solid Gastrointestinal Lesions: A Randomized Crossover Single-Center study Shivaraj Afzalpurkar, Vijay Kumar Rai, Nikhil Sonthalia, Gajanan Rodge, Awanesh Tewary, Mahesh Goenka Journal of Digestive Endoscopy.2023; 14(01): 014. CrossRef
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects María Victoria García-Ortiz, Pablo Cano-Ramírez, Marta Toledano-Fonseca, Enrique Aranda, Antonio Rodríguez-Ariza Biomarker Research.2023;[Epub] CrossRef
The impact of preoperative EUS-FNA for distal resectable pancreatic cancer: Is it really effective enough to take risks? Jin-Seok Park, Jae Hoon Lee, Tae Jun Song, Joune Seup Lee, Seok Jung Jo, Dong Wook Oh, Ki Byung Song, Dae Wook Hwang, Do Hyun Park, Sang Soo Lee, Song Cheol Kim, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim Surgical Endoscopy.2022; 36(5): 3192. CrossRef
Magnetic Resonance Imaging Radiomics‐Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study Zhenshan Shi, Chengle Ma, Xinming Huang, Dairong Cao Journal of Magnetic Resonance Imaging.2022; 55(3): 823. CrossRef
Role of Pathologist in the Era of Image-Guided and EUS-Guided Aspirations: A 10-Year Study at a Single Tertiary Care Oncology Institute in North India Gurudutt Gupta, Anila Sharma, Meenakshi Kamboj, Anurag Sharma, Sunil Pasricha, Garima Durga, Anurag Mehta, Avinash Rao Acta Cytologica.2022; 66(3): 187. CrossRef
Predicting Factors for Pancreatic Malignancy with Computed Tomography and Endoscopic Ultrasonography in Chronic Pancreatitis Jian-Han Lai, Keng-Han Lee, Chen-Wang Chang, Ming-Jen Chen, Ching-Chung Lin Diagnostics.2022; 12(4): 1004. CrossRef
Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study Wei Zhang, Ling Wang, Dan Li, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Qing Dong, Erkang Wang, Yuling Wang Analytical Methods.2022; 14(23): 2255. CrossRef
Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment Wei Zhang, Douglas H. Campbell, Bradley J. Walsh, Nicolle H. Packer, Dingbin Liu, Yuling Wang Journal of Nanobiotechnology.2022;[Epub] CrossRef
Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma Maroun Bou Zerdan, Malek Shatila, Dhruv Sarwal, Youssef Bouferraa, Morgan Bou Zerdan, Sabine Allam, Merima Ramovic, Stephen Graziano Cancers.2022; 14(19): 4589. CrossRef
Molecular Subtyping and Precision Medicine for Pancreatic Cancer Fieke Froeling, Raffaella Casolino, Antonio Pea, Andrew Biankin, David Chang Journal of Clinical Medicine.2021; 10(1): 149. CrossRef
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine R. Casolino, C. Braconi, G. Malleo, S. Paiella, C. Bassi, M. Milella, S.B. Dreyer, F.E.M. Froeling, D.K. Chang, A.V. Biankin, T. Golan Annals of Oncology.2021; 32(2): 183. CrossRef
Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Adenocarcinomas Revisited. A Detailed Cytological Analysis Mrinmay Kumar Mallik, Kusum Kapila, Asit Kumar Mohanty, Shafi Ahmed Inamdar, Ali AlAli, Abdullah Al Naseer Journal of Cytology.2021; 38(1): 31. CrossRef
Diagnostic value of various liquid biopsy methods for pancreatic cancer Yuzhou Zhu, Hao Zhang, Nan Chen, Jianqi Hao, Hongyu Jin, Xuelei Ma Medicine.2020; 99(3): e18581. CrossRef
Factors affecting cytological results of endoscopic ultrasound guided-fine needle aspiration during learning Jian-Han Lai, Hsiang-Hung Lin, Ching-Chung Lin Diagnostic Pathology.2020;[Epub] CrossRef
Comparison between Conventional Smear and Liquid-Based Preparation in Endoscopic Ultrasonography-Fine Needle Aspiration Cytology of Pancreatic Lesions Soo Hee Ko, Jung-Soo Pyo, Byoung Kwan Son, Hyo Young Lee, Il Whan Oh, Kwang Hyun Chung Diagnostics.2020; 10(5): 293. CrossRef
Evaluation of Pancreatic Lesions With Endoscopic Ultrasound and Fine Needle Aspiration Yan Luk, Wong Hoi She, Felix Che Lok Chow, Ka Wing Ma, Simon Hing Yin Tsang, Wing Chiu Dai, Tan To Cheung, Chung Mau Lo Surgical Innovation.2020; 27(5): 431. CrossRef
The applicability of Papanicolaou Society of Cytopathology system on reporting endoscopic ultrasound‐guided fine needle aspiration cytology specimens of pancreatic lesions in situations with limited availability of ancillary tests. Experience at a single Mrinmay Kumar Mallik, Laila Rafiq Qadan, Abdullah Al Naseer, Ali AlAli, Taiba Al Ansari, Shafi Ahmed Inamdar Naquib, Dilip Kumar Das, Kusum Kapila Cytopathology.2020; 31(6): 564. CrossRef
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer Marta Toledano-Fonseca, M. Teresa Cano, Elizabeth Inga, Rosa Rodríguez-Alonso, M. Auxiliadora Gómez-España, Silvia Guil-Luna, Rafael Mena-Osuna, Juan R. de la Haba-Rodríguez, Antonio Rodríguez-Ariza, Enrique Aranda Cancers.2020; 12(7): 1754. CrossRef
Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology Raza S. Hoda, Elizabeth B. Finer, Ronald N. Arpin, Matthew Rosenbaum, Martha B. Pitman Journal of the American Society of Cytopathology.2019; 8(3): 120. CrossRef
Endoscopic ultrasound guided fine‐needle aspiration vs core needle biopsy for solid pancreatic lesions: Comparison of diagnostic accuracy and procedural efficiency Aslam Syed, Olivia Babich, Bharat Rao, Shailendra Singh, Neil Carleton, Abhishek Gulati, Archana Kulkarni, Mrinal Garg, Katie Farah, Gursimran Kochhar, Suzanne Morrissey, Marcia Mitre, Abhijit Kulkarni, Manish Dhawan, Jan F. Silverman, Majed Pharaon, Shya Diagnostic Cytopathology.2019; 47(11): 1138. CrossRef
Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine Claudio Luchini, Nicola Veronese, Alessia Nottegar, Vera Cappelletti, Maria G. Daidone, Lee Smith, Christopher Parris, Lodewijk A. A. Brosens, Maria G. Caruso, Liang Cheng, Christopher L. Wolfgang, Laura D. Wood, Michele Milella, Roberto Salvia, Aldo Scar Cancers.2019; 11(8): 1152. CrossRef
It is necessary to exam bottom and top slide smears of EUS-FNA for pancreatic cancer Jong-chan Lee, Haeryoung Kim, Hyoung Woo Kim, Jongchan Lee, Kyu-hyun Paik, Jingu Kang, Jin-Hyeok Hwang, Jaihwan Kim Hepatobiliary & Pancreatic Diseases International.2018; 17(6): 553. CrossRef
Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancer Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park Gastrointestinal Endoscopy.2018; 88(6): 926. CrossRef
Cytological characteristics of atypical cells in endoscopic ultrasound-guided fine-needle aspiration specimens obtained from the pancreas Shikine ESAKA, Yoko MATSUDA, Yuri HAMASHIMA, Masayuki IMAIZUMI, Hiroya KOJIMA, Yuri KISO, Hiroto SHIRAHATA, Mayumi KINOSHITA, Akemi SUZUKI, Tomio ARAI The Journal of the Japanese Society of Clinical Cytology.2018; 57(4): 199. CrossRef
Performance measures for endoscopic retrograde cholangiopancreatography and endoscopic ultrasound: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative Dirk Domagk, Kofi W Oppong, Lars Aabakken, Laszlo Czakó, Tibor Gyökeres, Gianpiero Manes, Peter Meier, Jan-Werner Poley, Thierry Ponchon, Andrea Tringali, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Cesare Hassan, United European Gastroenterology Journal.2018; 6(10): 1448. CrossRef
Performance measures for ERCP and endoscopic ultrasound: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative Dirk Domagk, Kofi W. Oppong, Lars Aabakken, Laszlo Czakó, Tibor Gyökeres, Gianpiero Manes, Peter Meier, Jan-Werner Poley, Thierry Ponchon, Andrea Tringali, Cristina Bellisario, Silvia Minozzi, Carlo Senore, Cathy Bennett, Michael Bretthauer, Cesare Hassan Endoscopy.2018; 50(11): 1116. CrossRef
Imaging modalities for characterising focal pancreatic lesions Lawrence MJ Best, Vishal Rawji, Stephen P Pereira, Brian R Davidson, Kurinchi Selvan Gurusamy Cochrane Database of Systematic Reviews.2017;[Epub] CrossRef
Percutaneous ultrasound‐guided core needle biopsy of solid pancreatic masses: Results in 250 patients Guven Kahriman, Nevzat Ozcan, Serap Dogan, Soner Ozmen, Kemal Deniz Journal of Clinical Ultrasound.2016; 44(8): 470. CrossRef
Prostate Type Malignancies Arising in Ovarian Teratomas – A Report of Two Patients Shreeya Indulkar, Andres Matoso International Journal of Surgical Pathology.2025; 33(2): 408. CrossRef
Mixed neuroendocrine/Non-neuroendocrine neoplasm (MiNEN) of gastrointestinal lineage arising in an ovarian mature cystic teratoma Sandhyarani Dasaraju, Khalid Amin, Molly E. Klein, Colleen Rivard, Jordan Mattson, Sarah Davidson, Mahmoud A. Khalifa Gynecologic Oncology Reports.2022; 44: 101099. CrossRef
A Case of Mature Cystic Teratoma of the Mesentery Ryogo Ito, Motoi Yoshihara, Atsuki Arimoto, Taro Aoba, Yoshihisa Shibata, Kazuhiro Hiramatsu, Takehito Kato The Japanese Journal of Gastroenterological Surgery.2021; 54(5): 344. CrossRef
Synchronous colonic adenocarcinoma and well-differentiated neuroendocrine tumor arising in a mature cystic teratoma of ovary — rare presentation in a postmenopausal woman with literature review Pavithra Ayyanar, Jasmina Begum, Subhashree Rout, Pritinanda Mishra Indian Journal of Pathology and Microbiology.2021; 64(2): 385. CrossRef
Primary ovarian mixed strumal and mucinous carcinoid arising in an ovarian mature cystic teratoma Na Rae Kim, Seung Yeon Ha, Jin Woo Shin, Soyi Lim, Chan Yong Park, Hyun Yee Cho Journal of Obstetrics and Gynaecology Research.2016; 42(2): 211. CrossRef
Ewing’s Sarcoma Presenting in the Paranasal Sinus – A Case Report Yashika Kewalramani, Ajay Parihar, Prashanthi Reddy, Rashi Mandlik Annals of Maxillofacial Surgery.2024; 14(2): 228. CrossRef
Primary uterine Ewing sarcoma – A case report Yen-Chen Wu, Yu-Chien Kao, Ching-Wen Chang Taiwanese Journal of Obstetrics and Gynecology.2021; 60(1): 142. CrossRef
Adjuvant chemotherapy for a primitive neuroectodermal tumor of the uterine corpus: A case report and literature review Munetoshi Akazawa, Toshiaki Saito, Kazuya Ariyoshi, Masao Okadome, Ryohei Yokoyama, Kenichi Taguchi Journal of Obstetrics and Gynaecology Research.2018; 44(10): 2008. CrossRef
Clinicopathologic Features of the Non-CNS Primary Ewing Sarcoma Family of Tumors in the Head and Neck Region Chang Gok Woo, Bora Lee, Joon Seon Song, Kyung-Ja Cho Applied Immunohistochemistry & Molecular Morphology.2018; 26(9): 632. CrossRef
Primitive neuroectodermal tumor of uterus with synchronous in situ squamous cell carcinoma of cervix–A rare tumor with unusual association Ramneet Kaur, Shashi Dhawan, Prem Chopra, Sunita Bhalla Current Medicine Research and Practice.2017; 7(3): 109. CrossRef
Diagnostic Accuracy of the Partograph Alert and Action Lines to Predict Adverse Birth Outcomes: A Systematic Review M. Bonet, O. T. Oladapo, J. P. Souza, A. M. Gülmezoglu Obstetrical & Gynecological Survey.2020; 75(5): 269. CrossRef
Placental Mesenchymal Dysplasia Linda M. Ernst Journal of Fetal Medicine.2015; 02(03): 127. CrossRef
GTF2Imutation in micronodular thymoma with lymphoid stroma Andrea Bille, Katherine Fryer, Andrew Wallace, Daisuke Nonaka Journal of Clinical Pathology.2024; 77(2): 125. CrossRef
Minimally invasive thoracoscopic resection of a micronodular thymoma with lymphoid stroma via a subxiphoid single-incision approach: A case report Qiang Wu, Kun Qiao, Xiaoming Zhang, Zizi Zhou Medicine.2024; 103(36): e39637. CrossRef
Constant p.L424H Mutation in GTF2I in Micronodular Thymomas With Lymphoid Stroma: Evidence Supporting Close Relationship With Type A and AB Thymomas Min-Shu Hsieh, Hua-Lin Kao, Wen-Chang Huang, Shu-Ying Wang, Shin-Ying Lin, Ping-Yuan Chu, Chin-Chen Pan, Teh-Ying Chou, Hsiang-Ling Ho, Yi-Chen Yeh Modern Pathology.2023; 36(2): 100008. CrossRef
Comparative clinicopathological and immunohistochemical study of micronodular thymoma and micronodular thymic carcinoma with lymphoid stroma Ping Ping Liu, Yun Chao Su, Yun Niu, Yan Fen Shi, Jie Luo, Ding Rong Zhong Journal of Clinical Pathology.2022; 75(10): 702. CrossRef
Micronodular Thymoma With Lymphoid Stroma: A Trio of Cases, With Diverse-associated Histological Features Neha Bakshi, Shashi Dhawan, Seema Rao, Kishan Singh Rawat International Journal of Surgical Pathology.2021; 29(6): 693. CrossRef
A case of thymoma with type A and micronodular thymoma with lymphoid stroma elements Clayton E. Kibler, Matthew J. Cecchini, Marie-Christine Aubry, Said F. Yassin, Julie K. Harrington Human Pathology: Case Reports.2021; 23: 200487. CrossRef
Micronodular thymoma with lymphoid stroma: a clinicopathological study of five cases Katherine R. Hulme, Annabelle Mahar, Christopher Cao, Brian McCaughan, Wendy A. Cooper Pathology.2021; 53(7): 930. CrossRef
Mixed Type A Thymoma and Micronodular Thymoma With Lymphoid Stroma Renqing Wang, Ling Nie International Journal of Surgical Pathology.2018; 26(4): 336. CrossRef
Cystic Micronodular Thymoma. Report of a Case Mlika M Journal of Clinical, Medical and Experimental Images.2017; 1(1): 001. CrossRef
Two Invasive Thymomas Incidentally Found during Coronary Artery Bypass Graft Surgery Navid Omidifar, Maral Mokhtari, Mansoureh Shokripour Case Reports in Pathology.2016; 2016: 1. CrossRef
Metástasis tumor a tumor en pulmón: reporte de tres casos y revisión de la literatura Paula Cristina Castro Quiroga, Blanca Viviana Fajardo Idrobo, Diana Marcela Caicedo Ruiz, Julieth Alexandra Franco Mira, Carlos Andrés Carvajal Fierro, Alfredo Ernesto Romero Rojas, Rafael Santiago Parra Medina Revista Colombiana de Cancerología.2023; 27(1): 107. CrossRef
Benign Neurofibroma/Schwannoma Hybrid Peripheral Nerve Sheath Tumor of the Ulnar Nerve Harboring a Metastatic Papillary Thyroid Carcinoma Deposit: A Case Report of Tumor-to-Tumor Metastasis Juan M. Colazo, Alexander N. Perez, Anthony D. Judice, Julia Quirion, Carlos N. Prieto-Granada, Ginger E. Holt, Samir Sami Amr Case Reports in Pathology.2022; 2022: 1. CrossRef
A case of colorectal cancer with intratumoral metastasis to primary lung cancer Yasushi Cho, Mitsuhito Kaji, Shunsuke Nomura, Yusuke Motohashi, Masaaki Sato, Motoya Takeuchi The Journal of the Japanese Association for Chest Surgery.2021; 35(5): 576. CrossRef
Tumor-to-tumor metastasis: metastatic invasive lobular carcinoma of the breast within adenocarcinoma of the lung Myoung Jae Kang, Ae Ri An, Myoung Ja Chung, Kyoung Min Kim Journal of Pathology and Translational Medicine.2020; 54(2): 188. CrossRef
Metastatic Renal Cell Neoplasm Within a Papillary Thyroid
Carcinoma as Incidental Finding in an Asymptomatic Patient: a Case Report Maria-Rosa Bella-Cueto, Mireia Pascua-Solé, Albert Cano-Palomares, M. Àngels Cabezuelo-Hernandez, Maria-Rosa Escoda-Giralt, Santiago Barcons-Vilaplana, Paula Serret-Miralles, Carmen Caral-Vanaclocha, Xavier Guirao-Garriga, Joan Prats-Lopez, Meritxell Meda SN Comprehensive Clinical Medicine.2020; 2(7): 978. CrossRef
Squamous cell carcinoma of the lung and pulmonary metastasis of papillary thyroid carcinoma: a case report Arya Aminorroaya, Mohsen Khoshniatnikoo, Hossein Farrokhpour, Jamshid Vafaeimanesh, Mohammad Bagherzadeh Journal of Medical Case Reports.2019;[Epub] CrossRef
Pulmonary Metastasis of a Prostate Adenocarcinoma within a Primary Lung Adenocarcinoma: A Tumor-totumor Metastasis Case Report André Marcondes Braga Ribeiro, Ana Luiza Tatarin Vivan, Eduardo Nóbrega Pereira Lima, Maria Nirvana da Cruz Formiga, Mauro Daniel Spina Donadio, Felipe D'Almeida Costa Brazilian Journal of Oncology.2019;[Epub] CrossRef
Prostatic adenocarcinoma (PCa) metastasizing to renal cell carcinoma (RCC) with periureteral tumor deposit: A case of tumor-to-tumor metastasis (TTM) Jenissa Amor Dionisio Arceño, Jonathan Salcedo Mendoza, Josefino Cortez Castillo, Jeffrey Santos So Human Pathology: Case Reports.2017; 8: 27. CrossRef
Dual malignancy in a thyroid; papillary thyroid carcinoma and small lymphocytic lymphoma; a report of a case with a cyto‐histologic correlation Omar I. Ahmed, Ziyan T. Salih Diagnostic Cytopathology.2017; 45(9): 851. CrossRef
Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy Yuqin Ma, Xia Zhang, Yutao Wang Oncology Letters.2017;[Epub] CrossRef
Zinner Syndrome: Case report of atypical symptoms and literature Alejandro Acuña-Pacheco, Eduardo González-Rojas, Pedro Iván Aguilar-Ordaz, Joel Porfirio Rodelo-López, Benjamin Bueno-Mendoza, Israel Hernández-Rivera, Jose Rene Jungfermann-Guzman, Jesús Rodolfo Favela-Camacho Urology Case Reports.2025; 60: 102986. CrossRef
Zinner syndrome in pediatric patients: rare disease leading to challenging management Ottavio Adorisio, Cinzia Orazi, Lorenzo Maria Gregori, Francesco De Peppo, Massimiliano Silveri Frontiers in Pediatrics.2024;[Epub] CrossRef
Zinner syndrome: a rare diagnosis in infancy Joanne Michelle Oida Rose, Ravi Banthia, Zain Tamboli, Hira Lal BMJ Case Reports.2022; 15(5): e248558. CrossRef
Classifying seminal vesicle cysts in the diagnosis and treatment of Zinner syndrome: A report of six cases and review of available literature Zhengwu Tan, Bing Li, Lan Zhang, Ping Han, Haitao Huang, Andrew Taylor, Xin Li Andrologia.2020;[Epub] CrossRef
Incidental imaging findings suggesting Zinner syndrome in a young patient with pulmonary embolism: A case report Benedikt Hergan, Franz A. Fellner, Kaveh Akbari Radiology Case Reports.2020; 15(4): 437. CrossRef
Ectopic ureter associated with Zinner’s syndrome in a kidney recipient: case report and literature review Korhan Tuncer, Gizem Kilinc, Ismail Sert, Goksever Akpinar, Cem Tugmen Revista da Associação Médica Brasileira.2020; 66(5): 692. CrossRef
Zinner’s Syndrome: A Rare Diagnosis of Dysuria Based on Imaging Ahmed Ibrahimi, Abdelmoughit Hosni, Idriss Ziani, Fatima Zahra Laamrani, Hachem El Sayegh, Laila Jroundi, Lounis Benslimane, Yassine Nouini, Apul Goel Case Reports in Urology.2020; 2020: 1. CrossRef
Primary squamous cell carcinoma of the seminal vesicle Lu Fang, Qian Hong, Lei Chen, Yi Wang, Liang-Kuan Bi, Dong-Dong Xie, De-Xin Yu Medicine.2019; 98(12): e14788. CrossRef